ReviewMolecular medicine reports2026
Pyroptosis in cerebral ischemia‑reperfusion injury: Molecular mechanisms and therapeutic implications (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac arrest is a notable emergency in clinical medicine; following the return of spontaneous circulation, cerebral ischemia‑reperfusion (IR) injury remains a primary driver of persistently high mortality and adverse neurological outcomes. The pathophysiology of cerebral IR injury is multifaceted, involving oxidative stress, calcium overload and mitochondrial dysfunction. Pyroptosis has emerged as a focal research point, characterized by inflammasome‑dependent activation, membrane pore formation and the release of proinflammatory mediators. The present review highlighted the cell type‑specific roles of pyroptosis within the central nervous system during cerebral IR injury. The present review further examined its contribution to neuroinflammatory cascades, underscoring its pivotal role in driving neuronal damage. Furthermore, the underlying molecular mechanisms, the interplay between pyroptosis and other programmed cell death pathways and recent therapeutic advances targeting these processes were summarized. Collectively, the present review provided novel perspectives for improving post‑IR outcomes and advancing the clinical translation of neuroprotective strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.